BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 6817363)

  • 1. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents.
    Cumin R; Bandle EF; Gamzu E; Haefely WE
    Psychopharmacology (Berl); 1982; 78(2):104-11. PubMed ID: 6817363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats.
    Sakurai T; Ojima H; Yamasaki T; Kojima H; Akashi A
    Jpn J Pharmacol; 1989 May; 50(1):47-53. PubMed ID: 2724699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aniracetam reverses memory impairment in rats.
    Martin JR; Moreau JL; Jenck F
    Pharmacol Res; 1995 Feb; 31(2):133-6. PubMed ID: 7596957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats.
    Hsieh MT; Wu CR; Chen CF
    J Ethnopharmacol; 1997 Mar; 56(1):45-54. PubMed ID: 9147253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bifemelane hydrochloride (MCI-2016) on experimental amnesia (passive avoidance failure) in rodents.
    Tobe A; Yamaguchi T; Nagai R; Egawa M
    Jpn J Pharmacol; 1985 Oct; 39(2):153-61. PubMed ID: 4087564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions.
    Zajaczkowski W; Danysz W
    Pharmacol Biochem Behav; 1997 Jan; 56(1):21-9. PubMed ID: 8981605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents.
    Imanishi T; Sawa A; Ichimaru Y; Miyashiro M; Kato S; Yamamoto T; Ueki S
    Eur J Pharmacol; 1997 Mar; 321(3):273-8. PubMed ID: 9085037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of latencies for passive avoidance responses in rats treated with aniracetam or piracetam.
    Yamada K; Inoue T; Tanaka M; Furukawa T
    Pharmacol Biochem Behav; 1985 Apr; 22(4):645-8. PubMed ID: 3991773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of BY-1949 on three kinds of experimental amnesia in rodents].
    Tanabe S; Ikeda Y; Sugawa M; Iwasaki T
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):297-305. PubMed ID: 2251878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the novel compound NIK-247 on impairment of passive avoidance response in mice.
    Nabeshima T; Yoshida S; Kameyama T
    Eur J Pharmacol; 1988 Sep; 154(3):263-9. PubMed ID: 3234481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory traces.
    Piercey MF; Vogelsang GD; Franklin SR; Tang AH
    Brain Res; 1987 Oct; 424(1):1-9. PubMed ID: 3690290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aniracetam on one-trial passive avoidance tests and cholinergic neurons in discrete brain regions of rats.
    Toide K
    Arch Int Pharmacodyn Ther; 1989; 298():25-37. PubMed ID: 2757465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State dependent and/or direct memory retrieval by morphine in mice.
    Nishimura M; Shiigi Y; Kaneto H
    Psychopharmacology (Berl); 1990; 100(1):27-30. PubMed ID: 2296624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of piracetam's anti-amnesic activity in three models of amnesia in the mouse.
    Lenègre A; Chermat R; Avril I; Stéru L; Porsolt RD
    Pharmacol Biochem Behav; 1988 Mar; 29(3):625-9. PubMed ID: 3362958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oxiracetam on learning and memory in animals: comparison with piracetam.
    Mondadori C; Classen W; Borkowski J; Ducret T; Buerki H; Schadé A
    Clin Neuropharmacol; 1986; 9 Suppl 3():S27-38. PubMed ID: 3594453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of piracetam and of standardized ginseng extract on the electroconvulsive shock-induced memory disturbances in "step-down" passive avoidance.
    Lasarova MB; Mosharrof AH; Petkov VD; Markovska VL; Petkov VV
    Acta Physiol Pharmacol Bulg; 1987; 13(2):11-7. PubMed ID: 3673597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scopolamine amnesia of passive avoidance: a deficit of information acquisition.
    Rush DK
    Behav Neural Biol; 1988 Nov; 50(3):255-74. PubMed ID: 3202811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice).
    Petkov VD; Mosharrof AH; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(1):3-13. PubMed ID: 3136617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strength of scopolamine-induced amnesia as a function of time between training and testing.
    Quartermain D; Leo P
    Behav Neural Biol; 1988 Nov; 50(3):300-10. PubMed ID: 3202813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.